Pascal obtained his BSc Hons from Aberdeen University in Neuroscience with Psychology, researching the neurotrophic effects of Omega-3 fatty-acids, and graduated with an MSc from University College London in Clinical Mental Health Sciences in 2018, exploring wellbeing changes associated with the DMT experience. He is currently a PhD student at University of Greenwich with Dr. David Luke, investigating psychedelic and spiritual experiences, specifically the phenomenology and physiology of the DMT and near-death experience (NDE). He has a particular interest in how the scientific method can be harnessed, not least using psychedelics as ideal tools, to investigate the nature and transformative capacity of mystical-type and other ‘exceptional human experiences’ – and how the continuum of the molecular mechanisms to the humanistic experience of death and dying will inevitably illuminate the nature of life. His interests include psychedelic experiences and/or near-death experiences, neurobiological and subjective mechanisms of psychotherapeutic effects; Neural correlates; Experiential phenomenology.
Pascal Immanuel Michael reviews a randomised controlled trial examining long-term outcomes of psilocybin-assisted psychotherapy for existential distress in patients with cancer.[read the full story...]
Pascal Immanuel Michael summarises a recent RCT, which looks at how a single dose of the psychedelic Ayahuasca may help people with severe depression who have not benefited from more traditional treatment.[read the full story...]